Tag: Prescription Drugs
Gabapentin for Back Pain Linked to Increased Risk for Dementia, MCI
Further increase in risk was seen with prescription frequency, with higher risk for 12 or more prescriptions
Hypercholesterolemia Treatment Falls Short of Guidelines
In recent study, 23 percent of NHANES primary prevention cohort currently using lipid-lowering therapies versus 47 percent eligible under U.S. guidelines
Preschool Depression Intervention Has Long-Term Beneficial Effects
Those with remission at preadolescence have lower lifetime use of antipsychotics and intensive mental health interventions
NRTI Use Linked to Risk for Primary Open-Angle Glaucoma
Increased risk seen in adjusted analyses in association with nucleoside and nucleotide reverse transcriptase inhibitor use
Suspected Pharmacologic Triggers Do Not Appear to Cause Microscopic Colitis
No evidence of causal relationship seen between previously suspected medications and risk for microscopic colitis
Review Compares Efficacy, Safety of Treatments for Hidradenitis Suppurativa
Differences between adalimumab and other targeted treatments mainly not significant
FDA Will Now Require Labeling of ADHD Medication to Indicate Weight Loss Risk
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants
ADHD Medications Remain Linked to Lower Risk for Real-World Adverse Outcomes
Magnitude of these associations decreases alongside increasing prescription rates
Obesity Linked to Financial Hardship, Food Insecurity
People with obesity also reported greater cost-related medication nonadherence than those with overweight, normal weight
Liraglutide May Reduce Migraine Burden in Adults With Obesity, Migraine
Decrease seen in mean monthly headache days and reduction in Migraine Disability Assessment scores
